Seeking Alpha

Warner Chilcott (WCRX -0.9%) says a federal appeals court has vacated a lower court's ruling...

Warner Chilcott (WCRX -0.9%) says a federal appeals court has vacated a lower court's ruling that would have prevented Mylan (MYL +0.6%) from releasing a generic version of its Doryx acne drug until pending patent litigation was decided. The company says it will still vigorously defend its Doryx patent and intends to seek a new restraining order from the district court.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs